Zobrazeno 1 - 10
of 91
pro vyhledávání: '"Tečić Vuger, Ana"'
Publikováno v:
In Journal of Cancer Policy December 2024 42
Autor:
Linarić, Petra, Pavlović Mavić, Mirjana, Mirčevski, Karla, Meštrović, Josipa, Jakšić, Petra, Tečić Vuger, Ana, Vazdar, Ljubica, Šeparović, Robert
Results of our research showed that there was no statistically significant difference in duration of treatment between patients with luminal and non-luminal subtype, same as was reported in CLEOPATRA trial. Analyzing correlation between duration of t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=57a035e5b1ae::589e85c6a0cd9d7be0fd18de0b51fe36
https://www.bib.irb.hr/1274029
https://www.bib.irb.hr/1274029
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Tečić Vuger, Ana, Perić Balja, Melita, Jakšić, Petra, Linarić, Petra, Pavlović Mavić, Mirjana, Vazdar, Ljubica, Šeparović, Robert
Neoadjuvant, i.e. preoperative, systemic antineoplastic treatment (NAT), in patients with breast cancer enables in vivo monitoring of tumor response to applied therapy, tailoring treatment in real –time accordingly, sparing surgical procedures, bet
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=57a035e5b1ae::de798104747bb8dff63770095b3df808
https://www.bib.irb.hr/1260825
https://www.bib.irb.hr/1260825
Autor:
Pavlović Mavić, Mirjana, Šeparović, Robert, Vazdar, Ljubica, Tečić Vuger, Ana, Banović, Marija
Publikováno v:
Acta clinica Croatica
Volume 61.
Issue 4
Volume 61.
Issue 4
Body composition has been studied relatively recently as part of oncology trials in different types of tumors. There are numerous studies that define the impact of chemotherapy side effects on the quality of life (QoL) of breast cancer patients, howe
Autor:
Belac Lovasić, Ingrid, Bašić Koretić, Martina, Podolski, Paula, Dedić Plavetić, Natalija, Silovski, Tajana, Pleština, Stjepko, Jazvić, Marijana, Soldić, Željko, Šeparović, Robert, Tečić Vuger, Ana, Beketić Orešković, Lidija, Tomaš, Ilijan, Flam, Josipa, Petrić Miše, Branka, Ban, Marija, Telesmanić Dobrić, Vesna, Budisavljević, Anuška, Jović Zlatović, Josipa, Nalbani, Marijo, Vojnović, Željko, Marušić, Zlatko, Tomić, Snježana, Avirović, Manuela, Štambuk, Bojan, Vrdoljak, Danko Velimir, Prutki, Maja, Brkljačić, Boris, Tadić, Tade, Mijatović, Davor, Stanec, Zdenko, Milas, Ivan, Vrdoljak, Eduard
Publikováno v:
Liječnički vjesnik
Volume 144
Issue 9-10
Volume 144
Issue 9-10
Rak dojke je najčešći zloćudni tumor u žena koji se može probirom, redovitim kontrolama i zdravstvenim odgojem otkriti u ranim stadijima bolesti i uspješno liječiti. Metode liječenja uključuju kirurgiju, kemoterapiju, radioterapiju, endokri
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::8dbd0981fe58865eecc7604f4ae6e622
https://urn.nsk.hr/urn:nbn:hr:105:977208
https://urn.nsk.hr/urn:nbn:hr:105:977208
Autor:
Pavlović Mavić, Mirjana, Šeparović, Robert, Vazdar, Ljubica, Tečić Vuger, Ana, Jakšić, Petra, Linarić, Petra
Liver is the most common site of metastases from CRC.Surgical resection is the only treatment that offers a chance of long-term survival, however, only a minority of patients is suitable for upfront surgery. In patients with initially unresectable li
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=57a035e5b1ae::9b62f547cfa24924392587a5c5aa9e4a
https://doi.org/10.1016/j.annonc.2022.04.287
https://doi.org/10.1016/j.annonc.2022.04.287
Autor:
Linarić, Petra, Mirčevski, Karla, Vazdar, Ljubica, Tečić Vuger, Ana, Jakšić, Petra, Popović, Josipa, Trajbar, Mihaela, Pavlović Mavić, Mirjana, Šeparović, Robert
Osnova liječenja HER2-pozitivnog proširenog raka dojke je kombinacija HER2 blokade i kemoterapije. U metastatskom okruženju, osim učinkovitosti, od primarne su važnosti nuspojave liječenja i kvaliteta života (eng. QoL) bolesnika. U liječenju
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=57a035e5b1ae::0ec2905101b36803ad2766a893155837
https://www.bib.irb.hr/1262979
https://www.bib.irb.hr/1262979
Autor:
Vazdar, Ljubica, Linarić, Petra, Pavlović, Mirjana, Tečić Vuger, Ana, Šeparović, Robert, Jurić, Andreja
Abirateron acetate (AA) selectively inhibits the CYP17 enzyme resulting in a decrease in androgen synthesis in the adrenal glands, testicles and prostate tissue. Inhibition of CYP17 reduces serum cortisol levels and increases ACTH secretion through n
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=57a035e5b1ae::b1833ab60e54e605921b9c2b8fe147ff
https://www.bib.irb.hr/1262955
https://www.bib.irb.hr/1262955